Recurrence in Node-Positive Breast Cancer Treated With Tamoxifen
SAN ANTONIO, TX -- December 14, 2007 -- A 21-gene prognostic assay (Oncotype DX) predicts disease recurrence in patients with node-positive breast cancer who are treated with tamoxifen, according to a randomized trial.
Read entire article: http://www.docguide.com/news/content...2573B10059B6D2 |
All times are GMT -7. The time now is 03:49 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021